The 340B Rebate Model Discussion Returns: HRSA Sends Proposal to the White

As HRSA’s proposed 340B rebate model moves to the White House Office of Management and Budget (OMB) for review, covered entities are once again preparing for what could become one of the most significant operational shifts in the modern 340B program. At the same time, organizations across healthcare are already experiencing the growing complexity of IRA Maximum Fair Price (MFP) requirements, delayed submissions, reconciliation challenges, and evolving manufacturer expectations. Those pressures are raising important questions about what the next phase of 340B operations may require. Join PharmaForce leaders Lynn Eschenbacher, Chief Pharmacy and Strategy Officer, and Anthony Velasquez, Chief Product Officer, for a timely discussion breaking down the latest developments surrounding updates around HRSA’s rebate model, the operational realities organizations are beginning to face, and what covered entities should be evaluating now to prepare. This session will explore: The latest White House and HRSA developments surrounding the 340B rebate model proposal Key themes emerging from more than 5,500 public comments submitted to HRSA What organizations have learned from early IRA MFP operational workflows and how those lessons may apply to emerging rebate models Submission, reconciliation, and reimbursement challenges providers may face under future rebate structures Why visibility, claims-level data, staffing models, and operational infrastructure are becoming increasingly critical What health systems should evaluate now around workflows, reporting, reconciliation readiness, and product-level impact analysis As manufacturers, regulators, and policymakers continue reshaping the 340B landscape, organizations will need more than policy awareness alone. They will need operational readiness, connected workflows, and the ability to quickly understand program impact at both the claims and product level. Whether you are actively preparing for future rebate model requirements or trying to better understand how IRA and MFP initiatives may influence 340B operations moving forward, this webinar will provide practical guidance, strategic perspective, and actionable considerations for 340B leaders navigating a rapidly changing environment. Presented By: Lynn Eschenbacher, Chief Pharmacy and Strategy Officer and Anthony Velasquez, Chief Product Officer.